Endotherapy Devices Market Expected to Achieve 7.9% CAGR by 2029: Growth Forecast Insights

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

How Large Will the Endotherapy Devices Market Size By 2025?
The market size for endotherapy devices has experienced significant expansion in previous years. The market is projected to increase from $4.63 billion in 2024 to $4.91 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 6.0%. Factors contributing to this surge during the historical period include a higher incidence of gastrointestinal conditions, an ageing population, heightened public awareness and early detection, supportive reimbursement policies, worldwide economic growth, and strategic collaborations and partnerships.

How Big Is the Endotherapy Devices Market Size Expected to Grow by 2029?
The market for endotherapy devices is expected to witness robust expansion in the coming years, and is forecasted to reach "$6.64 billion by 2029, growing at a compound annual growth rate (CAGR) of 7.9%. The surge in this market during the projection period can be credited to the progress in minimally invasive procedures, the escalating incidence of chronic illnesses, the development of the healthcare infrastructure, greater emphasis on early diagnosis, regulatory assistance and standardization. Key trends to watch during the forecast period include progress in imaging technologies, the incorporation of artificial intelligence, technological innovations, worldwide growth of healthcare infrastructure, and a rising occurrence of gastrointestinal conditions.

View the full report here:
https://www.thebusinessresearchcompany.com/report/endotherapy-devices-global-market-report

Which Key Market Drivers Powering Endotherapy Devices Market Expansion and Growth?
The anticipated increase in gastrointestinal illnesses is predicted to boost the growth of the endotherapy devices market. Gastrointestinal conditions affect the digestive tract that extends from the mouth to the anus, which include ailments such as colorectal cancer, gastroesophageal reflux disease, ulcerative colitis (UC), inflammatory bowel disease (IBD), Crohn's disease (CD), among others. Endotherapy devices, utilized for non-invasive or minimally invasive surgical procedures in handling gastrointestinal diseases, are beneficial in treating and recognizing ulcers, bleeding, celiac disease, obstructions, inflammation and tumors in the gastrointestinal tract. Furthermore, these devices help in establishing the origin of unexplained signs like heartburn, abdominal discomfort, bleeding, nausea, vomiting, and pain. As an example, reports released by Cancer Australia, an organization based in Australia, in January 2024, forecasted 2,576 new stomach cancer cases in Australia in 2023, that includes 1,647 in males and 929 in females. The lifetime risk of being diagnosed by the age of 85 is estimated to be approximately 1 in 117 (0.85%), with males at a risk of 1 in 91 (1.1%) and females at 1 in 164 (0.61%). Hence, the surge in the number of gastrointestinal diseases is instigating the expansion of the endotherapy devices market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10157&type=smp

Which Fast-Growing Trends Are Poised to Disrupt the Endotherapy Devices Market?
Leading firms in the endotherapy devices market are creating innovative tools, such as red dichromatic imaging (RDI), which improve the visualisation of blood vessels and haemorrhage points during endoscopic processes. Such imaging techniques contribute to more accurate diagnosis by using two different wavelengths of light, thus enhancing the view of blood vessels and lesions. For example, Olympus Corporation, a medical technology firm based in Japan, introduced EVIS X1, an advanced endoscopy system, in October 2023. This state-of-the-art endoscopy system incorporates high-tech imaging technologies and artificial intelligence to bolster visualisation and diagnostic proficiency. The advanced imaging technologies employed by EVIS X1 optimise diagnostic efficiency. Its texture and colour enhancement imaging (TXI) raises the visibility of lesions and polyps by amplifying colour and texture. Red dichromatic imaging (RDI) targets deep blood vessels and points of bleeding, while brightness adjustment imaging with maintenance of contrast (BAI-MAC) offers a balance in the brightness levels throughout the image.

What Are the Emerging Segments in the Endotherapy Devices Market?
The endotherapy devices market covered in this report is segmented -

1) By Product: Gastrointestinal Devices and Accessories, Endoscopic Retrograde Cholangio Pancreatography Devices And Accessories, Other Endotherapy Devices
2) By Application: Bronchoscopy, Arthroscopy, Laparoscopy, Urology Endoscopy, Neuro-Endoscopy, Gastrointestinal Endoscopy, Other Applications
3) By End-Use: Hospital, Ambulatory Surgical Centers, Other End-Users

Subsegments:
1) By Gastrointestinal Devices And Accessories: Endoscopic Mucosal Resection (EMR) Devices, Endoscopic Submucosal Dissection (ESD) Devices, Biopsy Forceps, Clips And Closure Devices, Electrosurgical Devices
2) By Endoscopic Retrograde Cholangio Pancreatography (ERCP) Devices And Accessories: ERCP Cannulas, Balloon Sweep Devices, Stents, Guidewires, Sphincterotomes
3) By Other Endotherapy Devices: Endoscopic Ultrasound (EUS) Devices, Ablation Devices, Foreign Body Retrieval Devices, Laser Therapy Devices

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=10157&type=smp

Who Are the Global Leaders in the Endotherapy Devices Market?
Major companies operating in the endotherapy devices market include Olympus Corporation, Boston Scientific Corporation, Conmed Corporation, Medtronic Plc, Fujifilm Holdings Corporation, Johnson & JohnsonCook Group Incorporated, Karl Storz SE & Co. KG, Stryker Corporation, Taewoong Medical Co. Ltd, Smith & Nephew Plc., Steris Corporation, Micro-Tech (Nanjing) Co Ltd., HOYA Corporation, Cook Group Incorporated, B. Braun Melsungen AG, Frontier Healthcare, Pentax Medical, Nipro Corporation, MEDIVATORS B.V., US Endoscopy Group Inc., Richard Wolf GmbH, Cantel Medical Corp., Fujinon Corporation, Gyrus ACMI, Cogentix Medical Inc., Endogastric Solutions Inc.

Which are the Top Profitable Regional Markets for the Endotherapy Devices Industry?
North America as the largest region in the endotherapy devices market in 2024.Asia-Pacific is expected to be the fastest-growing region in the global endotherapy devices market report during the forecast period. The regions covered in the endotherapy devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10157

This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

UC24_fI0rV8cR5DxlCpgmyFQ

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.